Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Copying Valeant's Xifaxan just got 'a lot easier,' thanks to new FDA guidance: analyst
Copying Valeant's Xifaxan just got 'a lot easier,' thanks to new FDA guidance: analyst
Copying Valeant's Xifaxan just got 'a lot easier,' thanks to new FDA guidance: analyst
Submitted by
admin
on March 21, 2017 - 6:58pm
Source:
Fierce Pharma
News Tags:
Valeant Pharmaceuticals
Xifaxan
generics
FDA
IBS-d
Headline:
Copying Valeant's Xifaxan just got 'a lot easier,' thanks to new FDA guidance: analyst
Do Not Allow Advertisers to Use My Personal information
